In the fully adjusted model (Table 2), IGF-1 serum concentrations were not associated with the risk of ALS neither in crude nor in fully adjusted models (top vs. bottom quartile: OR 1.12; 95% CI 0.71,1.77, p for trend 0.53). This evidence concerns the gene IGF1 and amyotrophic lateral sclerosis.